Literature DB >> 6205428

Ocular involvement in Whipple's disease.

E J Selsky, D L Knox, A E Maumenee, W R Green.   

Abstract

A 60-year-old white man with recurrent nondeforming arthritis and no intestinal symptoms developed bilateral vitreous opacities strongly suggestive of Whipple's disease. He was successfully treated with tetracycline and erythromycin. Thirteen years later, a presumed diagnosis of Whipple's disease was established by histopathologic observation of macrophages that were distended by periodic acid-Schiff-positive material and the finding of bacilli by electron microscopy in a vitreous aspirate. The characteristics of ocular involvement in Whipple's disease are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6205428     DOI: 10.1097/00006982-198400420-00006

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  5 in total

1.  Intraocular PAS-positive macrophages simulating Whipple's disease.

Authors:  Frederick A Jakobiec; Alison B Callahan; Fouad R Zakka
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-06-07       Impact factor: 3.117

2.  Whipple's disease confined to the CNS presenting with multiple intracerebral mass lesions.

Authors:  S J Wroe; M Pires; B Harding; B D Youl; S Shorvon
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-11       Impact factor: 10.154

3.  Bilateral Ocular Myositis Associated with Whipple's Disease.

Authors:  Vivak Parkash; Hardeep Singh Mudhar; Bart E Wagner; Didier Raoult; Ruth Batty; Hubert Lepidi; John Burke; Paul Collini; Thushan de Silva
Journal:  Ocul Oncol Pathol       Date:  2016-09-07

4.  Diagnostic pars plana vitrectomy report of a 21-year retrospective study.

Authors:  G N Palexas; W R Green; M F Goldberg; Y Ding
Journal:  Trans Am Ophthalmol Soc       Date:  1995

5.  Postoperative panophthalmitis caused by Whipple disease.

Authors:  Michel Drancourt; Florence Fenollar; Danièle Denis; Didier Raoult
Journal:  Emerg Infect Dis       Date:  2009-05       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.